4
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001209191-20-052459
Director acquired 5,295,307 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Manning Paul B Director | 2020-09-28 | Conversion | +3,275,205 | 3,275,205 | I | ||
| Manning Paul B Director | 2020-09-28 | Conversion | +2,008,158 | 2,008,158 | I | ||
| Manning Paul B Director | 2020-09-28 | Conversion | +11,944 | 2,020,102 | I | ||
| Derivatives | |||||||
| Manning Paul B Director | 2020-09-28 | Conversion · Series A Preferred Stock | −3,006,155 | 0 | I | ||
| Manning Paul B Director | 2020-09-28 | Conversion · Series A Preferred Stock | −1,843,193 | 0 | I | ||
| Manning Paul B Director | 2020-09-28 | Conversion · Series B Preferred Stock | −10,963 | 0 | I | ||
Loading xslF345X03/doc4.xml…